# DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes

> **NCT07241897** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital of Soochow University** · enrollment: 312 (estimated)

## Conditions studied

- Ischemic Stroke
- Diabete Mellitus

## Interventions

- **DRUG:** Sentagliptin Phosphate - single dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07241897
- **Lead sponsor:** Second Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-04-30
- **Target enrollment:** 312 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07241897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07241897, "DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07241897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*